There has been an alarming amount of cancer survivors and the number continues to grow each year. Research and development have helped to expand technology improvements related to cancer treatments. The past 30 years have shown a large increase in the cancer survivor category by millions. In 2016, it was reported that there were approximately 15.5 million people who experienced successful cancer therapy. It’s estimated by 2040 those numbers will reach 26.1 million. People who are in remission have many different needs than most of us. They have to make sure that they continue to monitor the effects of treatment, continue with their scans and take certain medications.
Eric Lefkofsky is the co-founder and CEO of Tempus. He has dedicated much of his career to cancer research and detailed studies. As a successful entrepreneur, Lefkofsky created Tempus to help develop innovative and popular cancer treatments. Tempus helps work with many physicians and healthcare professionals by using cutting-edge technology utilizing genomic sequencing and methods of analysis. These are used to understand the necessary details needed to properly treat a patient’s tumor. By gathering large amounts of information and data, Tempus is able to better assist physicians so they are able to treat their patient’s properly. They can prescribe a more intense and personalized approach to therapy by utilizing high scaled technology. The data collected from Tempus is relayed to help doctors promote a more advanced plan of care and treatment for each patient.
Lefkofsky and his wife are fully engaged in the industry of cancer research. They regularly donate to research causes and have created a foundation called the Lefkofsky Family Foundation. They donated $1 million to the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Other donations have been made to give support to immunotherapy in relation to gastric cancer and breast cancer. He is also involved in The Giving Pledge and serves as a Trustee at Lurie Children’s Hospital of Chicago. As an entrepreneur, he has committed a lifetime of research to help those who are diagnosed with cancer. His future hope is to help those recover from the disease and remain in remission for a lifetime. With technology on the rise and a rapid growth with research, the success of survivors is increasing at a rapid rate.